Showing 10,941 - 10,960 results of 224,509 for search '(( a ((a decrease) OR (linear decrease)) ) OR ( a ((latent decrease) OR (larger decrease)) ))', query time: 1.92s Refine Results
  1. 10941

    S3 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  2. 10942

    S6 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  3. 10943

    Input parameters for the base-case analysis. by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  4. 10944

    S2 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  5. 10945

    S1 Data - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  6. 10946

    High levels of IFNγ partially restores <i>C</i>. <i>trachomatis</i> development in HeLa cells. by Shardulendra P. Sherchand (3133677)

    Published 2016
    “…As reported previously [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0163174#pone.0163174.ref019" target="_blank">19</a>], the addition of 300 U/mL IFNγ resulted in a statistically significant 2-log decrease in IFU recovery. …”
  7. 10947
  8. 10948

    Interhomolog polymorphism shapes meiotic crossover within the Arabidopsis <i>RAC1</i> and <i>RPP13</i> disease resistance genes by Heïdi Serra (488603)

    Published 2018
    “…We mapped crossover hotspots located in the <i>Arabidopsis thaliana RAC1</i> and <i>RPP13</i> disease resistance genes, using varying haplotypic combinations. We observed a negative non-linear relationship between interhomolog divergence and crossover frequency within the hotspots, consistent with polymorphism locally suppressing crossover repair of DSBs. …”
  9. 10949
  10. 10950
  11. 10951

    A novel <i>FLNC</i> frameshift and an <i>OBSCN</i> variant in a family with distal muscular dystrophy by Daniela Rossi (1716643)

    Published 2017
    “…<div><p>A novel <i>FLNC</i> c.5161delG (p.Gly1722ValfsTer61) mutation was identified in two members of a French family affected by distal myopathy and in one healthy relative. …”
  12. 10952
  13. 10953
  14. 10954
  15. 10955
  16. 10956

    Genome-wide association analysis identifies multiple loci associated with kidney disease-related traits in Korean populations by Jeonghwan Lee (286889)

    Published 2018
    “…<div><p>Chronic kidney disease (CKD) is an important social health problem characterized by a decrease in the kidney glomerular filtration rate (GFR). …”
  17. 10957

    Supplementary file 1_Early life predictors of child development at kindergarten: a structural equation model using a longitudinal cohort.docx by Sarah E. Turner (8478309)

    Published 2025
    “…Higher SES was related to a-0.26 (p-value =0.01) standardized decrease of EDI vulnerability, and this link was partially mediated through family stress at 3 years (10.6% mediated). …”
  18. 10958

    Table4_Eight weeks of dry dynamic breath-hold training results in larger spleen volume but does not increase haemoglobin concentration.XLSX by Kun Yang (19445)

    Published 2022
    “…Spleen sizes were measured with an ultrasound system and a complete blood cell analysis was performed on the median cubital venous blood.…”
  19. 10959

    Table1_Eight weeks of dry dynamic breath-hold training results in larger spleen volume but does not increase haemoglobin concentration.XLSX by Kun Yang (19445)

    Published 2022
    “…Spleen sizes were measured with an ultrasound system and a complete blood cell analysis was performed on the median cubital venous blood.…”
  20. 10960

    Table2_Eight weeks of dry dynamic breath-hold training results in larger spleen volume but does not increase haemoglobin concentration.XLSX by Kun Yang (19445)

    Published 2022
    “…Spleen sizes were measured with an ultrasound system and a complete blood cell analysis was performed on the median cubital venous blood.…”